Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain

被引:18
|
作者
Shannon, A. E. [1 ]
Chappell, K. J. [1 ]
Stoermer, M. J. [2 ]
Chow, S. Y. [2 ]
Kok, W. M. [2 ]
Fairlie, D. P. [2 ]
Young, P. R. [1 ,2 ]
机构
[1] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Dengue virus; Protease; NS2B-NS3; Cofactor inhibitor; YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; ENZYMATIC CHARACTERIZATION; STRUCTURAL PROTEINS; VIRAL REPLICATION; CLEAVAGE SITES; IN-VITRO; POLYPROTEIN; MUTAGENESIS; FLAVIVIRUS;
D O I
10.1016/j.pep.2015.11.022
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dengue Virus (DENV) infection is responsible for the world's most significant insect-borne viral disease. Despite an increasing global impact, there are neither prophylactic nor therapeutic options available for the effective treatment of DENV infection. An attractive target for antiviral drugs is the virally encoded trypsin-like serine protease (NS3pro) and its associated cofactor (NS2B). The NS2B NS3pro complex is responsible for cleaving the viral polyprotein into separate functional viral proteins, and is therefore essential for replication. Recombinant expression of an active NS2B-NS3 protease has primarily been based on constructs linking the C-terminus of the approximately 40 amino acid hydrophilic cofactor domain of NS2B to the N-terminus of NS3pro via a flexible glycine linker. The resulting complex can be expressed in high yield, is soluble and catalytically active and has been used for most in vitro screening, inhibitor, and X-ray crystallographic studies over the last 15 years. Despite extensive analysis, no inhibitor drug candidates have been identified yet. Moreover, the effect of the artificial linker introduced between the protease and its cofactor is unknown. Two alternate methods for bacterial expression of non-covalently linked, catalytically active, NS2B-NS3pro complex are described here along with a comparison of the kinetics of substrate proteolysis and binding affinities of substrate-based aldehyde inhibitors. Both expression methods produced high yields of soluble protein with improved substrate proteolysis kinetics and inhibitor binding compared to their glycine-linked equivalent. The non-covalent association between NS2B and NS3pro is predicted to be more relevant for examining inhibitors that target cofactor-protease interactions rather than the protease active site. Furthermore, these approaches offer alternative strategies for the high yield co-expression of other protein assemblies. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [21] Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease
    Lin, Cheng-Wen
    Huang, Hong-Da
    Shiu, Shi-Yi
    Chen, Wei-June
    Tsai, Ming-Hong
    Huang, Su-Hua
    Wan, Lei
    Lin, Ying-Ju
    VIRUS RESEARCH, 2007, 127 (01) : 88 - 94
  • [22] Comparison of static and dynamic pharmacophore models for virtual screening for inhibitors of dengue virus NS2B/NS3 protease
    Kokpol, Sirirat
    Wichapong, Kanin
    Pianwanit, Somsak
    Sippl, Wolfgang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [23] Design and Docking Studies of Peptide Inhibitors as Potential Antiviral Drugs for Dengue Virus Ns2b/Ns3 Protease
    Velmurugan, Devadasan
    Mythily, Udhayakumar
    Rao, Kutumba
    PROTEIN AND PEPTIDE LETTERS, 2014, 21 (08): : 815 - 827
  • [24] Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease
    Saqallah, Fadi G.
    Abbas, Manal A.
    Wahab, Habibah A.
    PHYTOCHEMISTRY, 2022, 202
  • [25] Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction
    Wichapong, Kanin
    Pianwanit, Somsak
    Sippl, Wolfgang
    Kokpol, Sirirat
    JOURNAL OF MOLECULAR RECOGNITION, 2010, 23 (03) : 283 - 300
  • [26] Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease
    de la Cruz, Laura
    Chen, Wan-Na
    Graham, Bim
    Otting, Gottfried
    FEBS JOURNAL, 2014, 281 (06) : 1517 - 1533
  • [27] Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors
    Saleem, Hafiza N.
    Kousar, Summara
    Jiskani, Ammar Hassan
    Sohail, Iqra
    Faisal, Amir
    Saeed, Muhammad
    ARCHIV DER PHARMAZIE, 2023, 356 (11)
  • [28] A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus
    da Costa, Renato A.
    da Rocha, Joao A. P.
    Pinheiro, Alan S.
    da Costa, Andreia do S. S.
    da Rocha, Elaine C. M.
    Silva, Rai. C.
    Goncalves, Arlan da S.
    Santos, Cleydson B. R.
    Brasil, Davi do S. B.
    MOLECULES, 2022, 27 (13):
  • [29] DENGUE VIRUS PROTEASE NS2B/NS3 WITH A POTENTIAL INHIBITION OF THE TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY
    Anglero, Yesseinia I.
    Pantoja, Petraleigh
    Gracia, Gabriel
    Sariol, Carlos A.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 123 - 123
  • [30] Exploring the antiviral inhibitory activity of Niloticin against the NS2B/ NS3 protease of Dengue virus (DENV2)
    Stalin, Antony
    Han, Jiajia
    Reegan, Appadurai Daniel
    Ignacimuthu, Savarimuthu
    Liu, Shuwen
    Yao, Xingang
    Zou, Quan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 277